THE ROLE OF SCHEDULE DEPENDENCY OF 5-FLUOROURACIL LEUCOVORIN COMBINATIONS IN ADVANCED COLORECTAL-CANCER

被引：0
作者：
SCHOBER, C [1 ]
BOKEMEYER, C [1 ]
STAHL, M [1 ]
WILKE, HJ [1 ]
SCHMOLL, HJ [1 ]
POLIWODA, H [1 ]
机构：
[1] UNIV ESSEN GESAMTHSCH KLINIKUM,GERMAN CANC CTR,W-4300 ESSEN 1,GERMANY
来源：
SEMINARS IN ONCOLOGY | 1992年 / 19卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：131 / 135
页数：5
相关论文
共 50 条
[41]   CHEMOTHERAPY OF ADVANCED COLORECTAL-CANCER - A RANDOMIZED TRIAL OF SEQUENTIAL METHOTREXATE AND 5-FLUOROURACIL [J].
MACKINTOSH, J ;
COATES, A ;
SWANSON, C ;
RAGHAVAN, D ;
TATTERSALL, MHN .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (03) :210-212
[42]   5-FLUOROURACIL PLUS TAUROMUSTINE IN ADVANCED COLORECTAL-CANCER - UNEXPECTED NEGATIVE RESULTS [J].
TAAL, BG ;
HUININK, WWT ;
FRANKLIN, HR ;
MCVIE, JG .
EUROPEAN JOURNAL OF CANCER, 1990, 26 (07) :856-856
[43]   PHASE-II STUDY OF 5-FLUOROURACIL PLUS LEUCOVORIN AND INTERFERON ALPHA-2B IN ADVANCED COLORECTAL-CANCER [J].
SOBRERO, A ;
NOBILE, MT ;
GUGLIELMI, A ;
MORI, A ;
ASCHELE, C ;
BOLLI, E ;
TIXI, L ;
GALLO, L ;
PARODI, GC ;
BRUZZI, P ;
BREMA, F ;
ROSSO, R .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (4-5) :850-852
[44]   ACTIVITY OF CONTINUOUS-INFUSION 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER CLINICALLY RESISTANT TO BOLUS 5-FLUOROURACIL [J].
MORI, A ;
BERTOGLIO, S ;
GUGLIELMI, A ;
ASCHELE, C ;
BOLLI, E ;
TIXI, L ;
ROSSO, R ;
SOBRERO, A .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 33 (02) :179-180
[45]   RANDOMIZED COMPARISON OF FLUOROURACIL AND LEUCOVORIN THERAPY VERSUS FLUOROURACIL, LEUCOVORIN, AND CISPLATIN THERAPY IN PATIENTS WITH ADVANCED COLORECTAL-CANCER [J].
SCHEITHAUER, W ;
DEPISCH, D ;
KORNEK, G ;
PIDLICH, J ;
ROSEN, H ;
KARALL, M ;
PROCHASKA, M ;
ERNST, A ;
SEBESTA, C ;
ECKHARDT, S .
CANCER, 1994, 73 (06) :1562-1568
[46]   Is oral tegafur with leucovorin equivalent to intravenous 5-fluorouracil and leucovorin in colorectal cancer? [J].
Friberg, G. ;
Schilsky, R. L. .
NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (05) :240-241
[47]   Is oral tegafur with leucovorin equivalent to intravenous 5-fluorouracil and leucovorin in colorectal cancer? [J].
Gregory Friberg ;
Richard L Schilsky .
Nature Clinical Practice Oncology, 2006, 3 :240-241
[48]   Trimetrexate as a biochemical modulator of 5-fluorouracil and leucovorin in colorectal cancer [J].
Punt, CJA .
SEMINARS IN ONCOLOGY, 2000, 27 (05) :88-90
[49]   Randornised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer [J].
Nogué, M ;
Salud, A ;
Batiste-Alentorn, E ;
Saigí, E ;
Losa, F ;
Cirera, L ;
Méndez, M ;
Campos, JM ;
Galan, A ;
Escudero, P ;
Arcusa, A ;
Manzano, H ;
de Mendizábal, EV ;
de Olaguer, JP ;
Boleda, M ;
Guasch, I ;
Vicente, P .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (15) :2241-2249
[50]   INTRAPORTAL 5-FLUOROURACIL FOR COLORECTAL-CANCER - THE AXIS TRIAL [J].
GARTEN, L ;
STENNING, S ;
GRAY, R .
LANCET, 1992, 340 (8825) :985-985
12345